Delivery Order SPE2DB20D3103-SPE2DB25FP8Z6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,690.52 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery...
- The Defense Logistics Agency awarded a $23,377.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $17,703.31 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector (2-pack), with a ceiling value of $2,065.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of federal pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,143.65 to AmerisourceBergen Drug Corp for the supply of epinephrine 0.3 mg auto-injector 2-packs. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. This delivery order is performed from the vendor's corporate office in Conshohocken, Pennsylvania, and represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,874.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a ceiling value of $2,724.24. This competitive, firm fixed-price delivery order is set to be completed by August 15, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine procurement action under the pharmaceutical supply chain supporting federal medical needs,...
- The Defense Logistics Agency awarded a $2,689.26 delivery order to AmerisourceBergen Drug Corp for the procurement of Epinephrine 0.3 mg auto-injector units (2-pack) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $31,845.97. This firm fixed-price delivery order, which is expected to be completed by August 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.28 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by July 21, 2025. The order was issued on July 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8Z6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,905.66 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medical products to support military healthcare systems, the Defense Health Agency, and other government healthcare entities. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement needs through competitive processes, positioning it as a key supplier within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/15/25 |